Think Bioscience Inc.
The Թ of Colorado Connection
Think Bioscience is a Boulder-based synthetic biology company with strong roots at CU Boulder. The company was spun out of 's lab (CU Boulder Department of Chemical and Biological Engineering and BioFrontiers Institute), where its foundational technology, leveraging microbial systems to discover small-molecule drugs for previously “undruggable” targets, was developed. Its lead programs, including inhibitors of PTP1B, emerged directly from this academic research.
Funding Status and Investment Opportunities
- Industry Applications: Health and Wellness, Biotech, Therapeutics
- Funding Stage: Series B
- Contact for Investment Inquiries: , jfox@thinkbioscience.com
In the News
- Think Bioscience raises $55M in oversubscribed Series A (2026)
- Think Bioscience, a CU Boulder spinout, raises $26M to find ‘pockets’ for drug therapies (2024)
- Six CU Boulder startups selected to present at the Rocky Mountain Life Science Investor Conference (2024)
- Jerome Fox elevated to senior member of prestigious National Academy of Inventors (2024)
- CU Boulder spinout Think Bioscience raises $17M to target undruggable proteins (2022)
Venture Partners Programs
- Destination Startup (2022)
- Lab Venture Challenge(2020)
- Intellectual Property Management (2018)
Technology Development Funding
U.S. National Science Foundation (NSF)
This page was last updated on May 16, 2025. Please email vpnews@colorado.edu for corrections or updates
The Insider Investor E-Newsletter
Media Inquiries
For marketing inquiries and news tips, contact Daniel Leonard,senior marketing and communications specialist for Venture Partners at CU Boulder.
For media inquiries, please visit .